InvestorsObserver
×
News Home

Is Harpoon Therapeutics Inc (HARP) Stock a Bad Value Tuesday?

Tuesday, March 05, 2024 12:34 PM | InvestorsObserver Analysts

Mentioned in this article

Is Harpoon Therapeutics Inc (HARP) Stock a Bad Value Tuesday?

A rating of 76 puts Harpoon Therapeutics Inc (HARP) near the top of the Healthcare sector according to InvestorsObserver. Harpoon Therapeutics Inc's score of 76 means that it ranks higher than 76% of stocks in the sector. In addition, its overall score of 79 ranks it higher than 79% of all stocks.

Overall Score - 79
HARP has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on HARP!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Harpoon Therapeutics Inc Stock Today?

Harpoon Therapeutics Inc (HARP) stock has gained 0.09% while the S&P 500 is lower by -0.78% as of 12:34 PM on Tuesday, Mar 5. HARP is higher by $0.02 from the previous closing price of $22.96 on volume of 824,962 shares. Over the past year the S&P 500 has risen 25.75% while HARP is higher by 209.29%. HARP lost -$8.71 per share the over the last 12 months. Click Here to get the full Stock Report for Harpoon Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App